Vascular turnover during carrageenan synovitis in the rat

Laboratory Investigation

Volumn 78, Issue 12, 1998, Pages 1513-1521

  Walsh, David Andrew ^a,b   Rodway, Helen Anne ^b   Claxson, Andrew ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; SUBSTANCE P; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CELL INFILTRATION; CELL PROLIFERATION; ENDOTHELIUM LESION; HISTOPATHOLOGY; KNEE ARTHRITIS; MACROPHAGE MIGRATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SYNOVITIS;

ANIMALS; CARRAGEENAN; ENDOTHELIUM, VASCULAR; HUMANS; IN SITU NICK-END LABELING; JOINTS; MACROPHAGES; MALE; NEOVASCULARIZATION, PATHOLOGIC; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR; SYNOVIAL MEMBRANE; SYNOVITIS; TIME FACTORS;

EID: 0032408615     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ben Ezra D (1978). Vasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants. Am J Ophthalmol 86:455-461.
2. Čeponis A, Konttinen Y, Mackevicius Z, Solovieva SA, Hukkanen M, Tamulaitien M, Matulis A, and Santavirta S (1996). Aberrant vascularity and von Willebrand factor distribution in inflamed synovial membrane. J Rheumatol 23:1880-1886.
3. Čeponis A, Konttinen YT, Imai S, Tamulaitiene M, Li TF, Xu J-W, Hietanen J, Santavirta S, and Fassebender H-G (1998). Synovial lining, endothelial and inflammatory mononuclear cell proliferation in synovial membranes in psoriatic and reactive arthritis: A comparative quantitative morphometric study. Br J Rheumatol 37:170-178.
4. Chu CQ, Field M, Feldmann M, and Maini RN (1991). Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 34:1125-1132.
5. Dijkstra CD, Dopp EA, Jolling P, and Kraal G (1985). The heterogeneity of mononuclear phagocytes in lymphoid organs; distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54:589-599.
6. Di Rosa M., Papadimitriou JM, and Willoughby DA (1971). A histopathological and pharmacological analysis of the mode of action of non-steroidal anti-inflammatory drugs. J Pathol 105:239-256.
7. 1 or interleukin-1 receptor antagonists. Br J Pharmacol 110:43-49.
8. Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, Jackman RW, Senger DR, Dvorak HF, and Brown LF (1994). Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180:341-346.
9. 2 and angiogenesis. Proc Soc Exp Biol Med 172:214-218.
10. 9-bradykinin inhibits the angiogenic effect of bradykinin and interleukin-1 in rats. Br J Pharmacol 109:14-17.
11. Knight AD and Levick JR (1983). The density and distribution of capillaries around the synovial cavity. Q J Exp Physiol 68:629-644.
12. Koch AE, Friedman J, Burrows JC, Haines GK, and Bouck NP (1993). Localization of the angiogenesis inhibitor thrombospondin in human synovial tissues. Pathobiology 61:1-6.
13. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, and Ferrara N (1994). Vascular endothelial growth factor: A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152:4149-4156.
14. Laitenen L (1987). Griffonia simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissues. Histochem J 19:225-234.
15. Lam FY and Ferrell WR (1989). Inhibition of carrageenan induced inflammation in the rat knee joint by substance P antagonist. Ann Rheum Dis 48:928-932.
16. Lam FY and Ferrell WR (1991). Neurogenic component of different models of acute inflammation in the rat knee joint. Ann Rheum Dis 50:747-751.
17. Levick JR (1990). Hypoxia and acidosis in chronic inflammatory arthritis: Relation to vascular supply and dynamic effusion pressure. J Rheumatol 17:579-582.
18. Male D, Rahman J, Linke A, Zhao W, and Hickey WF (1995). An interferon inducible molecule on brain endothelium which controls lymphocyte adhesion mediated by integrins. Immunology 84:453-460.
19. Mapp PI, Kidd BL, Gibson SJ, Terry JM, Revell PA, Ibrahim NBN, Blake DR, and Polak JM (1990). Substance P-, calcitonin gene-related peptide-and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience 37:143-153.
20. Mapp PI, Walsh DA, Garrett NE, Kidd BL, Cruwys SC, Polak JM, and Blake DR (1994). Effect on nerve fibres in the synovium of three animal models of inflammation. Ann Rheum Dis 53:240-246.
21. Meininger CJ and Zetter BR (1992). Mast cells and angiogenesis. Semin Cancer Biol 3:73-79.
22. Nagashima M, Yoshino S, Ishiwata T, and Asano G (1995). Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 22:1624-1630.
23. Peacock DJ, Banquerigo ML, and Brahn E (1992). Angiogenesis inhibition suppresses collagen arthritis. J Exp Med 175:1135-1138.
24. Peacock DJ, Banquerigo ML, and Brahn E (1995). A novel angiogenesis inhibitor suppresses rat adjuvant arthritis. Cell Immunol 160:178-184.
25. Qu Z, Huang XN, Ahmadi P, Andresevic J, Planck SR, Hart CE, and Rosenbaum JT (1995). Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease. Lab Invest 73:339-346.
26. Sanna PP, Jirikowski GF, Lewandowski GA, and Bloom FE (1992). Applications of DAPI cytochemistry to neurobiology. Biotech Histochem 67:346-350.
27. Shu S, Ju G, and Fan L (1988). The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 85:169-171.
28. Stevens CR, Blake DR, Merry P, Revell PA, and Levick JR (1991). Comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum 34:1508-1513.
29. Walsh DA, Hu D-E, Mapp PI, Polak JM, Blake DR, and Fan T-PD (1996). Substance P and new vessel formation in the rat subcutaneous sponge granuloma. Histochem J 28:759-769.
30. Walsh DA, Mapp PI, Wharton J, Polak JM, and Blake DR (1993a). Neuropeptide degrading enzymes in normal and inflamed human synovium. Am J Pathol 142:1610-1621.
31. Walsh DA, Salmon M, Mapp PI, Wharton J, Garrett N, Blake DR, and Polak JM (1993b). Microvascular substance P binding to normal and inflamed rat and human synovium. J Pharmacol Exp Ther 267:951-960.
32. Walsh DA, Wade M, Mapp PI, and Blake DR (1998). Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol 152:691-702.
33. Waseem NH and Lane DP (1990). Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA): Structural conservation and the detection of a nucleolar form. J Cell Sci 96:121-129.
34. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Geppetti P, and Ledda F (1994). Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94:2036-2044.